The report provides a comprehensive overview of the UK independent healthcare and social care sectors, including data on market value, capacity, trends, leading players, funding sources, and key issues. It highlights the role of private payers and independent sector providers, alongside the public sector, in the funding and delivery of UK health and care services.
Addus HomeCare Corp. (ADUS)
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
Company Info
Highlights
Related Tickers
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Addus HomeCare Corp., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Addus HomeCare Corp. (ADUS) has returned -15.19% so far this year and -5.19% over the past 12 months. Looking at the last ten years, ADUS has achieved an annualized return of 18.33%, outperforming the Benchmark (SPY), which averaged 12.23% per year.
ADUS
Benchmark (SPY)
Monthly Returns
The table below presents the monthly returns of Addus HomeCare Corp. (ADUS) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.19% | -0.17% | -8.31% | -2.62% | ||||||||
| 2025 | -0.19% | -23.26% | 2.76% | 6.36% | 6.21% | 3.93% | -6.77% | 7.87% | 2.21% | -0.09% | 2.59% | -10.23% |
| 2024 | -6.52% | 6.55% | 11.59% | -7.49% | 19.54% | 1.08% | 4.00% | 9.22% | 0.66% | -6.08% | -1.48% | 1.93% |
| 2023 | 7.84% | 1.82% | -0.46% | -23.90% | 7.83% | 3.26% | -1.22% | -7.24% | -3.04% | -6.95% | 10.52% | 6.71% |
| 2022 | -15.25% | 6.65% | 10.21% | -9.32% | -1.08% | -0.57% | 12.33% | -3.96% | 7.64% | 7.04% | 2.96% | -10.51% |
| 2021 | -4.32% | -4.42% | -3.24% | 0.81% | -9.49% | -9.06% | -0.78% | 3.52% | -12.93% | 16.16% | -8.19% | 5.26% |
| 2020 | -3.18% | -19.57% | -10.76% | 25.89% | 24.01% | -6.99% | 3.86% | -3.42% | 1.56% | 2.37% | 0.69% | 17.10% |
| 2019 | -10.10% | 12.49% | -6.04% | 5.96% | 0.41% | 9.59% | 6.39% | 9.05% | -9.47% | 6.34% | 8.51% | 4.02% |
| 2018 | 2.72% | -3.78% | 42.04% | 7.03% | 9.05% | -0.52% | 16.36% | -2.33% | 8.34% | -6.95% | 12.88% | -9.12% |
| 2017 | -3.53% | -6.67% | -2.29% | 6.26% | 9.44% | -9.10% | 0.44% | 3.22% | 0.42% | -7.88% | 4.50% | |
| 2016 | 7.87% | 8.28% | -15.18% | 8.45% | 27.49% | 8.23% | -2.47% | 36.88% | 0.43% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Addus HomeCare Corp. (ADUS) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of ADUS compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Addus HomeCare Corp. volatility is 1.15%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 1.41B | 1.02B | 937.99M | 947.59M | 892.58M | 636.75M | 355.39M | 267.11M | 231.03M | 192.61M | 180.80M | 163.93M | 149.86M | 154.69M |
| Equity Attributable To Parent (USD) | 970.49M | 706.69M | 633.54M | 574.34M | 518.68M | 475.59M | 275.53M | 175.08M | 158.93M | 141.73M | 127.96M | 113.86M | 94.42M | 86.44M |
| Equity Attributable To Noncontrolling Interest (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity (USD) | 970.49M | 706.69M | 633.54M | 574.34M | 518.68M | 475.59M | 275.53M | 175.08M | 158.93M | 141.73M | 127.96M | 113.86M | 94.42M | 86.44M |
| Other Non-current Liabilities (USD) | - | 48.48M | 41.54M | 34.64M | 35.13M | 13.74M | 1.07M | - | - | - | - | - | - | - |
| Long-term Debt (USD) | - | 124.13M | 131.77M | 220.91M | 194.87M | 59.89M | 17.28M | 42.96M | 25.01M | - | - | - | 16.46M | - |
| Noncurrent Liabilities (USD) | 286.27M | 172.62M | 173.31M | 255.55M | 230.01M | 73.63M | 18.35M | 39.86M | 22.48M | 8.70M | 9.64M | 3.44M | 16.25M | 24.96M |
| Other Current Liabilities (USD) | 128.70M | 118.93M | 109.05M | 98.33M | 120.20M | 67.89M | 49.27M | 47.90M | 45.13M | 37.44M | 39.25M | 42.00M | 35.07M | 38.03M |
| Accounts Payable (USD) | 27.18M | 26.18M | 22.09M | 19.36M | 23.71M | 19.64M | 12.24M | 4.27M | 4.49M | 4.75M | 3.95M | 4.63M | 4.12M | 5.27M |
| Current Liabilities (USD) | 155.87M | 145.12M | 131.15M | 117.69M | 143.90M | 87.53M | 61.50M | 52.17M | 49.62M | 42.19M | 43.21M | 46.64M | 39.19M | 43.29M |
| Liabilities (USD) | 442.14M | 317.73M | 304.45M | 373.24M | 373.91M | 161.16M | 79.86M | 92.03M | 72.10M | 50.89M | 52.85M | 50.08M | 55.44M | 68.25M |
| Other Non-current Assets (USD) | 1.02B | 708.43M | 621.82M | 540.44M | 513.59M | 298.13M | 135.44M | 91.94M | 77.96M | 71.08M | 65.39M | 61.06M | 53.16M | 55.30M |
| Intangible Assets (USD) | 109.64M | 91.98M | 72.19M | 64.32M | 71.55M | 57.08M | 23.78M | 16.60M | 15.41M | 10.35M | 10.35M | 8.76M | 6.37M | 8.04M |
| Fixed Assets (USD) | 24.70M | 24.01M | 21.18M | 18.48M | 19.75M | 12.16M | 10.66M | 7.49M | 6.65M | 8.62M | 7.70M | 2.63M | 2.49M | 2.49M |
| Noncurrent Assets (USD) | 1.15B | 824.42M | 715.19M | 623.24M | 604.89M | 367.36M | 169.88M | 116.03M | 100.02M | 90.05M | 83.43M | 72.45M | 62.02M | 65.83M |
| Current Assets (USD) | 260.38M | 200.00M | 222.81M | 324.34M | 287.70M | 269.39M | 185.50M | 151.09M | 131.01M | 102.56M | 97.37M | 91.48M | 87.84M | 88.86M |
| Assets (USD) | 1.41B | 1.02B | 937.99M | 947.59M | 892.58M | 636.75M | 355.39M | 267.11M | 231.03M | 192.61M | 180.80M | 163.93M | 149.86M | 154.69M |
News and Insights

Centene Corporation is set to report its second-quarter 2024 results. The company's performance is expected to have benefited from enhanced volumes and contributions from its Commercial business, but declining total memberships and growing cost ratio might affect second-quarter profits.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Telsey Advisory Group cut the price target for Big Lots, Inc. (NYSE:BIG) from $5 to $2.5. Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating. Big Lots shares dipped 18.2% to close at $2.88 on Thursday. See how other analysts view this stock. Oppenheimer raised the price target for Addus HomeCare Corporation (NASDAQ:ADUS) from $118 to $130. Oppenheimer analyst Michael Wiederhorn maintained an Outperform rating. Addus HomeCare shares rose 1.2% to close at $116.07 on Thursday. See how other analysts view this stock. Oppenheimer increased Microsoft Corporation (NASDAQ:MSFT) price target from $450 to $500. Oppenheimer analyst Timothy Horan maintained an Outperform rating. Microsoft shares gained 0.1% to close at $424.52 on Thursday. See how other analysts view this stock. B of A Securities ...Full story available on Benzinga.com

Addus HomeCare (NASDAQ:ADUS) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 1 1 0 Last 30D 0 1 0 0 0 1M Ago 2 1 0 0 0 2M Ago 0 0 0 1 0 3M Ago 0 1 1 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $109.86, a high estimate of $128.00, and a low estimate of $83.00. A decline of 4.05% from the prior average price target is evident in the current average. Understanding Analyst Ratings: A Comprehensive Breakdown A clear picture of Addus HomeCare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Scott Fidel Stephens & Co. Raises Overweight $128.00 $120.00 Ryan Langston TD Cowen Raises Buy $119.00 $105.00 Scott Fidel Stephens & Co. Maintains Overweight $115.00 - Joanna Gajuk B of A Securities Raises Buy $118.00 $115.00 Andrew Mok Barclays Announces Underweight $83.00 - Michael Wiederhorn Oppenheimer Maintains Outperform $118.00 $118.00 Andrew Mok Barclays Announces Equal-Weight $88.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to ...Full story available on Benzinga.com

DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.

We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.

The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 10% and 1.16%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Here is how Addus HomeCare (ADUS) and HCA Healthcare (HCA) have performed compared to their sector so far this year.